Aquestive Therapeutics In... (AQST)

NASDAQ: AQST · Real-Time Price · USD

3.01

0.08 (2.91%)

At close: May 01, 2025, 3:59 PM

2.90

-3.65%

After-hours: May 01, 2025, 07:55 PM EDT

Aquestive Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	57.56M	50.58M	47.68M	50.83M	45.85M	52.61M	67.43M	66.92M	51.78M
Cost of Revenue	17.87M	20.83M	19.39M	14.99M	12.96M	20.36M	20.99M	19.82M	16.38M
Gross Profit	39.69M	29.75M	28.29M	35.84M	32.88M	32.25M	46.44M	47.1M	35.41M
Operating Income	-30.77M	-15.1M	-42.07M	-34.68M	-42.89M	-52.67M	-48.93M	-113K	-847K
Interest Income	3.44M	16.32M	99K	423K	132K	636K	552K	n/a	n/a
Pretax Income	-44.15M	-7.63M	-54.41M	-70.54M	-55.78M	-66.25M	-61.38M	-8.94M	-9.6M
Net Income	-44.14M	-7.87M	-60.2M	-90.04M	-65.36M	-72.66M	-61.38M	-8.94M	-9.6M
Selling & General & Admin	50.18M	31.75M	52.88M	53.48M	55.89M	64.34M	72.26M	25.08M	20.8M
Research & Development	20.28M	13.1M	17.48M	17.05M	19.89M	20.57M	23.11M	22.13M	15.45M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-5K	n/a	-99K
Operating Expenses	70.46M	44.85M	70.36M	70.52M	75.78M	84.92M	95.38M	47.21M	36.25M
Interest Expense	16.82M	7.46M	12.44M	22.46M	13.02M	9.32M	7.71M	7.71M	6.14M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	88.33M	65.69M	89.75M	85.51M	88.74M	105.28M	116.36M	67.03M	52.63M
Income Tax Expense	-14K	245K	5.79M	19.5M	9.58M	6.41M	-4.73M	7.71M	6.04M
Shares Outstanding (Basic)	86.73M	61.26M	48.73M	38.08M	33.65M	25.36M	20.73M	20M	24.5M
Shares Outstanding (Diluted)	86.73M	61.26M	48.73M	38.08M	33.65M	25.36M	20.73M	20M	24.5M
EPS (Basic)	-0.51	-0.13	-1.24	-2.36	-1.94	-2.87	-2.96	-0.45	-0.39
EPS (Diluted)	-0.51	-0.13	-1.24	-2.36	-1.94	-2.87	-2.96	-0.45	-0.39
EBITDA	-26.62M	1.18M	-39.58M	-45.11M	-39.15M	-53.88M	-50.33M	2.56M	2.94M
EBIT	-27.33M	-163K	-41.97M	-48.08M	-42.76M	-56.93M	-53.66M	-1.24M	-3.46M
Depreciation & Amortization	718K	1.34M	2.39M	2.96M	3.61M	3.05M	3.34M	3.8M	3.89M